Montanide Isa-51
Adult Soft Tissue Sarcoma
National Cancer Institute (NCI)Phase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Adult Soft Tissue Sarcoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ezabenlimab Institut Bergonié | Phase 2 | CCC |
bi 907828 Institut Bergonié | Phase 2 | CCC |
Mage-12 Peptide Vaccine National Cancer Institute (NCI) | Phase 1 | CC |
Same molecule, other indications
Montanide Isa-51 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →